Case Report: Application of multimodal imaging in the diagnosis and treatment evaluation of primary cardiac lymphoma.
Primary cardiac lymphoma (PCL) is an extremely rare malignancy.
APA
Shi H, Liang J (2026). Case Report: Application of multimodal imaging in the diagnosis and treatment evaluation of primary cardiac lymphoma.. Frontiers in cardiovascular medicine, 13, 1732686. https://doi.org/10.3389/fcvm.2026.1732686
MLA
Shi H, et al.. "Case Report: Application of multimodal imaging in the diagnosis and treatment evaluation of primary cardiac lymphoma.." Frontiers in cardiovascular medicine, vol. 13, 2026, pp. 1732686.
PMID
41869531
Abstract
Primary cardiac lymphoma (PCL) is an extremely rare malignancy. This report describes a 76-year-old woman who presented with chest tightness, exertional dyspnea, and nocturnal orthopnea. Multimodal imaging (echocardiography, CT, CMR, PET) was central to the diagnostic process, enabling precise tumor localization, non-invasive tissue characterization, and disease staging, thereby raising strong suspicion for PCL. The diagnosis of primary cardiac diffuse large B-cell lymphoma (non-germinal center subtype) was subsequently confirmed by histopathology. The patient achieved complete remission after five cycles of chemotherapy, which was confirmed on 6-month follow-up imaging, with no recurrence over 65 months of surveillance. This case highlights that multimodal imaging provides complementary information crucial for the comprehensive evaluation of PCL, serving as a cornerstone for evidence-based clinical decision-making throughout the diagnostic and therapeutic continuum, from initial suspicion and staging to treatment response assessment.
같은 제1저자의 인용 많은 논문 (5)
- Revisional Asian Blepharoplasty of the High Eyelid Fold: Tarsus-Orbicularis Fixation Combined With Orbital Fat Repositioning Technique.
- A retrospective study of primary breast augmentation: recovery period, complications and patient satisfaction.
- DISCERN: Dual-Aptamer-Initiated Sensing Circuit Engineered Nanozyme for Leukemia Stem Cells Phenotyping.
- A phase II study evaluating pharmacokinetics and dosimetry of Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer.
- LncRNA MCF2L-AS1 promotes malignant progression of colorectal cancer by post-transcriptional activation of MCF2L.